Annual Cash & Cash Equivalents
$143.74 M
-$8.06 M-5.31%
December 31, 2023
Summary
- As of February 7, 2025, RLAY annual cash & cash equivalents is $143.74 million, with the most recent change of -$8.06 million (-5.31%) on December 31, 2023.
- During the last 3 years, RLAY annual cash & cash equivalents has fallen by -$303.91 million (-67.89%).
- RLAY annual cash & cash equivalents is now -67.89% below its all-time high of $447.65 million, reached on December 31, 2020.
Performance
RLAY Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$152.36 M
+$18.23 M+13.59%
September 1, 2024
Summary
- As of February 7, 2025, RLAY quarterly cash and cash equivalents is $152.36 million, with the most recent change of +$18.23 million (+13.59%) on September 1, 2024.
- Over the past year, RLAY quarterly cash and cash equivalents has increased by +$1.03 million (+0.68%).
- RLAY quarterly cash and cash equivalents is now -72.76% below its all-time high of $559.28 million, reached on September 30, 2020.
Performance
RLAY Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RLAY Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.3% | +0.7% |
| 3 y3 years | -67.9% | -33.3% |
| 5 y5 years | -65.9% | - |
RLAY Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.7% | at low | -57.0% | +41.4% |
| 5 y | 5-year | -67.9% | +242.6% | -72.8% | +263.1% |
| alltime | all time | -67.9% | +242.6% | -72.8% | +263.1% |
Relay Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $152.36 M(+13.6%) |
| Jun 2024 | - | $134.13 M(-12.3%) |
| Mar 2024 | - | $152.87 M(+6.4%) |
| Dec 2023 | $143.74 M(-5.3%) | $143.74 M(-5.0%) |
| Sep 2023 | - | $151.33 M(+3.7%) |
| Jun 2023 | - | $145.90 M(-9.5%) |
| Mar 2023 | - | $161.28 M(+6.2%) |
| Dec 2022 | $151.79 M | $151.79 M(-57.2%) |
| Sep 2022 | - | $354.64 M(+229.2%) |
| Jun 2022 | - | $107.74 M(-9.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $119.44 M(-57.4%) |
| Dec 2021 | $280.12 M(-37.4%) | $280.12 M(+22.6%) |
| Sep 2021 | - | $228.56 M(-12.1%) |
| Jun 2021 | - | $260.07 M(-1.0%) |
| Mar 2021 | - | $262.72 M(-41.3%) |
| Dec 2020 | $447.65 M(+967.0%) | $447.65 M(-20.0%) |
| Sep 2020 | - | $559.28 M(+308.1%) |
| Jun 2020 | - | $137.05 M(+94.8%) |
| Mar 2020 | - | $70.34 M(+67.7%) |
| Dec 2019 | $41.95 M(-90.0%) | $41.95 M |
| Dec 2018 | $421.50 M | - |
FAQ
- What is Relay Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Relay Therapeutics?
- What is Relay Therapeutics annual cash & cash equivalents year-on-year change?
- What is Relay Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Relay Therapeutics?
- What is Relay Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Relay Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of RLAY is $143.74 M
What is the all time high annual cash & cash equivalents for Relay Therapeutics?
Relay Therapeutics all-time high annual cash & cash equivalents is $447.65 M
What is Relay Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, RLAY annual cash & cash equivalents has changed by -$8.06 M (-5.31%)
What is Relay Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RLAY is $152.36 M
What is the all time high quarterly cash and cash equivalents for Relay Therapeutics?
Relay Therapeutics all-time high quarterly cash and cash equivalents is $559.28 M
What is Relay Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, RLAY quarterly cash and cash equivalents has changed by +$1.03 M (+0.68%)